Quick links

Contact us
Customer support
Login

Main Menu

Home
Technology
Products
Knowledge
Media
About us
- About XVIVO
- History
- Our market
- News
- Career
- Working at XVIVO
Corporate

Contact us
Customer support

Home
Technology
Products
Knowledge
Media
About us
- About XVIVO
- History
- Our market
- News
- Career
- Working at XVIVO
Corporate

Corporate
The share
Press releases
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
Financial calendar
Financial reports
Financial reports – ESEF
Prospectus and material offerings
- Material offerings
- Prospectus
Financial presentations
- Capital Markets Day
- Earnings calls
Corporate governance
Analyst Coverage
Code of Conduct
Environmental Policy
Code of Conduct for Suppliers
Privacy policy
Contact us
Subscribe
Thank you
Error

Press releases 2021

All press releases
Regulatory Press Releases

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

2021-04-21 07:30

News

IR

Swedish

Regulatory

MAR

Report

Interim

Q1

Delårsrapport januari-mars 2021

2021-03-29 12:35

News

IR

Swedish

Regulatory

VPML

Report

Annual

Årsredovisning 2020

2021-03-29 12:35

News

IR

English

Regulatory

VPML

Report

Annual

Annual report 2020

2021-03-15 08:50

News

IR

English

Regulatory

Listing Regulation

Corporate Information

General meeting

Notice

Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ)

2021-03-15 08:50

News

IR

Swedish

Regulatory

Listing Regulation

Corporate Information

General meeting

Notice

Kallelse till årsstämma i XVIVO Perfusion AB (publ)

2021-01-28 07:30

News

IR

Swedish

Regulatory

MAR

Report

Interim

Yearend

XVIVO offentliggör bokslutskommuniké 2020

2021-01-28 07:30

News

IR

English

Regulatory

MAR

Report

Interim

Yearend

XVIVO presents Report on operations 2020

About us

Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives.
Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine.
XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on three continents. The company is listed on Nasdaq.

Contact

Swedish Office
XVIVO Perfusion AB
Box 53015
SE-400 14 Göteborg
Sweden

Phone: +46 31 788 21 50
Fax: +46 31 788 21 69
info@xvivogroup.com

Report a violations or breach here: Whistleblower

Home
Technology
Products
Knowledge
Media
About us
Corporate

Copyright © 2023 XVIVO. All rights reserved.

Design mkmedia

To top

We use cookies to improve the user experience on XVIVO. Read more about Cookies

Approve